ERICA HARRIS: Open Payments
NPI 1790323947 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $175 |
| ACADIA Pharmaceuticals Inc | 1 | $71 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: INGREZZA, NUPLAZID, AUSTEDO XR, REXULTI.
Industry payments across OR — which companies pay providers there.
